HIIFS
MRNA icon

Harel Insurance Investments & Financial Services’s Moderna MRNA Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,250
Closed -$35K – 473
2025
Q1 		$35K Sell
1,250
-13,750
-92% -$488K ﹤0.01% 391
2024
Q4 		$624K Buy
+15,000
New +$717K 0.01% 147
2024
Q3 		– Sell
-11,190
Closed -$1.36M – 543
2024
Q2 		$1.36M Buy
+11,190
New +$1.42M 0.03% 147
2024
Q1 		– Sell
-720
Closed -$71K – 601
2023
Q4 		$71K Hold
720
– – ﹤0.01% 391
2023
Q3 		$72K Sell
720
-9,160
-93% -$1.02M ﹤0.01% 415
2023
Q2 		$1.21M Sell
9,880
-13,163
-57% -$1.76M 0.03% 131
2023
Q1 		$3.4M Buy
23,043
+10,262
+80% +$1.69M 0.07% 109
2022
Q4 		$2.28M Buy
+12,781
New +$2.09M 0.05% 122
2022
Q2 		– Sell
-140
Closed -$24K – 774
2022
Q1 		$24K Sell
140
-10,264
-99% -$1.73M ﹤0.01% 619
2021
Q4 		$2.61M Buy
10,404
+8,518
+452% +$2.49M 0.05% 111
2021
Q3 		$726K Sell
1,886
-1,308
-41% -$482K 0.02% 186
2021
Q2 		$2.45M Sell
3,194
-2,394
-43% -$428K 0.05% 174
2021
Q1 		$2.44M Buy
5,588
+1,579
+39% +$229K 0.05% 220
2020
Q4 		$1.35M Sell
4,009
-712
-15% -$72K 0.03% 245
2020
Q3 		$334K Sell
4,721
-279
-6% -$19.5K 0.01% 237
2020
Q2 		$321K Buy
5,000
+3,900
+355% +$214K 0.01% 183
2020
Q1 		$33K Buy
+1,100
New +$25.3K ﹤0.01% 298
2019
Q4 		– Sell
-386
Closed -$6K – 530
2019
Q3 		$6K Buy
+386
New +$5.7K ﹤0.01% 466

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Harel Insurance Investments & Financial Services's MRNA Position: Q2 2025 in Review

Harel Insurance Investments & Financial Services sold out of Moderna (MRNA) in Q2 2025, closing a stake of 1,250 shares — an estimated $35K sold.

Harel Insurance Investments & Financial Services first reported a position in MRNA in Q3 2019 and held it in 18 quarters. The position peaked at $3.4M in Q1 2023. 675 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Harel Insurance Investments & Financial Services reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 1,250 Moderna shares in Q2 2025, an estimated $35K.
  • Harel Insurance Investments & Financial Services first reported a position in Moderna in Q3 2019 and held it in 18 quarters.
  • Harel Insurance Investments & Financial Services's Moderna position peaked at $3.4M in Q1 2023.
  • 675 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2025, filed 5 Aug 2025.